Phase I/II study of biweekly docetaxel, cisplatin, and S-1 combination neoadjuvant chemotherapy in patients with stage III gastric cancer - Phase I/II study of biweekly docetaxel, cisplatin, and S-1 combination neoadjuvant chemotherapy in patients with stage III gastric cancer

Yokohama City University Medical Center0 个研究点目标入组 51 人开始时间: 2013年9月2日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1. with active double cancer within 5 years except intramucosal cancer 2. with a history of severe allergy 3. with active infectious disease(over 38 degrees C) 4. Women in pregnancy, at risk of pregnancy, or hoping to become pregnant. 5. Men who want their partners to become pregnant 6. with a history of cardiac infarction in recent 6 months 7. with a continuous administration of steroids 8. patient who needs continuous administration of Flucytosine, fenitoin or walfarin karium 9. with ulceration on digestive tract and/or bleeding from the ulcer 10. with uncontrollable diarrhea or watery stool 11. with active hepatitis B Ag and/or hepatitis C Ab 12. with serious complication as followings, -Interstitial pneumonia -Pulmonary fibrosis -paralysis on bowel -ischemic heart diseases 13. Any patients judged by the investigator to be unfit to participate in the study

发起方